
Marksans Pharma Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Marksans Pharma Limited's wholly owned subsidiary Time-Cap Laboratories, Inc, receives Establishment Inspection Report from US FDA".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Marksans Pharma Limited's wholly owned subsidiary Time-Cap Laboratories, Inc, receives Establishment Inspection Report from US FDA".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma